Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions-Reference-Cited by-同舟云学术

Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions

Published:2016-09-01 Issue:17 Volume:73 Page:1331-1337
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Li Quan¹,Liu Zhaoying²,Kolli Shamalatha³,Wetz Karen⁴,Griffith Niesha¹,Poi Ming J.⁵

Affiliation:

1. Department of Pharmacy, James Comprehensive Cancer Hospital and Richard Solove Research Institute, Ohio State University Wexner Medical Center, Columbus, OH

2. College of Veterinary Medicine, Hunan Agricultural University, Hunan, China

3. College of Pharmacy, Ohio State University, Columbus, OH

4. Department of Pharmacy, Ohio State University Wexner Medical Center, Columbus, OH

5. Division of Pharmacy Practice and Science, College of Pharmacy, Ohio State University, Columbus, OH, and Department of Pharmacy, James Comprehensive Cancer Hospital and Richard Solove Research Institute, Ohio State University Wexner Medical Center, Columbus, OH

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/73/17/1331/28334131/ajhp1331.pdf

Reference19 articles.

1. Anticancer oral therapy: emerging related issues;Banna;Cancer Treat Rev,2010

2. Adherence to oral antineoplastic agents by cancer patients: definition and literature review;Bassan;Eur J Cancer Care,2014

3. Overview of the changing paradigm in cancer treatment: oral chemotherapy;Aisner;Am J Health-Syst Pharm,2007

4. NCCN Task Force report: oral chemotherapy;Weingart;J Natl Compr Canc Netw,2008

5. Patient preferences for oral versus intravenous palliative chemotherapy;Liu;J Clin Oncol,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternatives for the administration of oral antineoplastics in patients with swallowing difficulties;Journal of Chemotherapy;2024-05-20

2. Medication use process and assessment of extemporaneous compounding and alternative routes of administration of oral oncology drugs: Guidance for clinical and oncology pharmacists;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2022-09-12

3. Alternate dosage formulations of oral targeted anticancer agents;Journal of Oncology Pharmacy Practice;2021-09-24

4. Patient and Family-Centered Care for Pediatric Intraluminal Pulmonary Vein Stenosis: Case of a 3 Year Old Patient with Focus on Nurse Practitioner Role;Children;2021-07-01

5. A guide for the administration of oral antineoplastic in patients with swallowing disorders;FARM HOSP;2021